$26.74
-0.09-0.34%
At Close: -
$26.74
00.00%
After Hours: Sep 20, 4:03 PM EDT
15 minutes delayed
BridgeBio Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BridgeBio Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $-1.06 | $-1.04 | -1.92 % |
Mar 2024 | 2024-05-02 | $-0.20 | $-0.89 | 77.5 % |
Dec 2023 | 2024-02-22 | $-0.96 | $-0.91 | -5.49 % |
Sep 2023 | 2023-11-02 | $-1.08 | $-0.81 | -33.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $2.17M | $3.57M | -39.3 % |
Mar 2024 | 2024-05-02 | $211.12M | $14.03M | 1404.8 % |
Dec 2023 | 2024-02-22 | $1.75M | $6.23M | -72.0 % |
Sep 2023 | 2023-11-02 | $4.09M | $4.26M | -3.97 % |
BridgeBio Pharma (BBIO) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $-1.06, which missed the estimate of $-1.04.
The Actual Revenue was $2.2M, which missed the estimate of $3.6M.
Browse earnings estimates, EPS, and revenue on all stocks.